Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fuyumi Nishihara
Observed names:
F. Nishihara,
Nishihara, Fuyumi
Institutions:
Saitama International Medical Center,
Saitama Medical University
Observed institutions:
Saitama International Medical Center,
Saitama Medical University
ORCID:
0000-0002-3999-6752
Observed ORCID:
0000-0002-3999-6752
OpenAlex ID:
A5060315536
Works
75
Awards
1
CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy
2019
·
Hiroshi Kagamu
, Shigehisa Kitano
, et al.
·
Cancer Immunology Research
·
288
Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients
2019
·
Ayako Shiono
, Kyoichi Kaira
, et al.
·
Thoracic Cancer
·
81
PDF
Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events
2020
·
Yu Miura
, Atsuto Mouri
, et al.
·
Thoracic Cancer
·
61
PDF
Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab
2019
·
Ou Yamaguchi
, Kyoichi Kaira
, et al.
·
Thoracic Cancer
·
57
PDF
Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer
2019
·
Atsuto Mouri
, Kyoichi Kaira
, et al.
·
Cancer Chemotherapy and Pharmacology
·
52
Omalizumab Attenuates Airway Inflammation and Interleukin-5 Production by Mononuclear Cells in Patients with Severe Allergic Asthma
2013
·
Yotaro Takaku
, Tomoyuki Soma
, et al.
·
International Archives of Allergy and Immunology
·
51
Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy
2022
·
Hiroshi Kagamu
, Satoshi Yamasaki
, et al.
·
Cancer Research
·
47
PDF
Severe hepatotoxicity due to osimertinib after nivolumab therapy in patients with non‐small cell lung cancer harboring EGFR mutation
2020
·
Ou Yamaguchi
, Kyoichi Kaira
, et al.
·
Thoracic Cancer
·
38
PDF
Different incidence of interstitial lung disease according to different kinds of EGFR‐tyrosine kinase inhibitors administered immediately before and/or after anti‐PD‐1 antibodies in lung cancer
2019
·
Takahiro Uchida
, Kyoichi Kaira
, et al.
·
Thoracic Cancer
·
35
PDF
Mycobacterium gordonae-induced humidifier lung
2015
·
Harue Utsugi
, Yutaka Usui
, et al.
·
BMC Pulmonary Medicine
·
25
PDF
Trans-basement membrane migration of eosinophils induced by LPS-stimulated neutrophils from human peripheral bloodin vitro
2015
·
Fuyumi Nishihara
, Kazuyuki Nakagome
, et al.
·
ERJ Open Research
·
21
PDF
Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation
2019
·
Ou Yamaguchi
, Kyoichi Kaira
, et al.
·
Cancer Chemotherapy and Pharmacology
·
20
Changes in Airway Inflammation and Hyperresponsiveness after Inhaled Corticosteroid Cessation in Allergic Asthma
2010
·
Yotaro Takaku
, Kazuyuki Nakagome
, et al.
·
International Archives of Allergy and Immunology
·
14
Combination therapy with carboplatin and paclitaxel for small cell lung cancer
2018
·
Atsuto Mouri
, Ou Yamaguchi
, et al.
·
Respiratory Investigation
·
12
Effect of Formoterol on Eosinophil Trans-Basement Membrane Migration Induced by Interleukin-8-Stimulated Neutrophils
2013
·
Akiko Kawashima
, Tomoko Suzuki
, et al.
·
International Archives of Allergy and Immunology
·
12
Eosinophil transendothelial migration induced by the bronchoalveolar lavage fluid of acute eosinophilic pneumonia
2017
·
Kazuyuki Nakagome
, Hisakazu Shoda
, et al.
·
Respirology
·
8
[Questionnaire for determining relationship between nasal and asthma symptoms].
2010
·
Hiroto Nakada
, Kazuyuki Nakagome
, et al.
·
PubMed
·
7
Combination of immune check inhibitor and immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: A case report
2021
·
Kunihiko Kobayashi
, Kyoichi Kaira
, et al.
·
Molecular and Clinical Oncology
·
6
PDF
CD4+ T cells in PBMC to predict the outcome of anti-PD-1 therapy.
2017
·
Hiroshi Kagamu
, Ou Yamaguchi
, et al.
·
Journal of Clinical Oncology
·
6
Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1
2022
·
Ou Yamaguchi
, Kazuyuki Atarashi
, et al.
·
BMC Cancer
·
3
PDF
Correlation between T cell immunity and the duration of EGFR-TKI resistance acquisition in patients harboring EGFR mutations
2025
·
Atsuto Mouri
, Kyoichi Kaira
, et al.
·
Cancer Immunology Immunotherapy
·
2
PDF
Trans-Basement Membrane Migration of Eosinophils Induced By LPS-Stimulated Neutrophils from Human Peripheral Blood in Vitro
2016
·
Kazuyuki Nakagome
, Fuyumi Nishihara
, et al.
·
Journal of Allergy and Clinical Immunology
·
2
PDF
[Rapid specific IgE assay (ImmunoCAP® RAPID) and skin prick test in the diagnosis of allergic disease].
2013
·
Kenichiro Komiyama
, Ai Masumoto
, et al.
·
PubMed
·
2
Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation
2019
·
Ou Yamaguchi
, Kyoichi Kaira
, et al.
·
Cancer Chemotherapy and Pharmacology
·
1
PDF
Clinical Benefit of Chemotherapy for Small-Cell Lung Cancer Patients with Extremely Poor Performance Status (PS)
2018
·
Ou Yamaguchi
, Hiroshi Kagamu
, et al.
·
Annals of Cancer Research and Therapy
·
1
PDF
Show more works
View as search
Works count:
75
Citation count:
853
H-index:
13
I10-index:
15
Year
Topic
Type